CHIANG MAI UNIVERSITY

Their core work

Chiang Mai University is a major Thai research university with growing involvement in EU-funded international research, particularly through staff exchange programs (MSCA-RISE). Their H2020 contributions span two distinct domains: advanced polymer and biomaterials research for medical applications (drug delivery, wound care), and digital manufacturing systems for SMEs. They serve as a Southeast Asian knowledge node, bringing regional expertise in cultural heritage digitization, polymer science, and regional integration studies to European consortia.

What they specialise in

How they've shifted over time

CMU's early H2020 involvement (2016-2018) centered on digital technologies and regional studies — Industry 4.0 manufacturing systems and Southeast Asian cultural heritage digitization. By 2020, their focus shifted decisively toward life sciences, specifically biomedical polymer design for medical devices and drug delivery. This pivot from digital/industrial topics to biomaterials research signals a strategic move into health-oriented materials science.

CMU is moving toward biomedical materials science, making them an increasingly relevant partner for health-tech and medical device projects needing polymer expertise from a Southeast Asian institution.

How they like to work

CMU exclusively participates as a partner or third party — they have never coordinated an H2020 project. With 35 unique consortium partners across 22 countries, they operate as a well-connected but non-leading contributor, typically joining large international consortia through MSCA-RISE staff exchange schemes. This makes them a low-risk addition to consortia seeking a Southeast Asian research node without expecting project leadership.

Despite only 4 projects, CMU has built a surprisingly broad network of 35 partners across 22 countries, reflecting the large multi-partner structure of MSCA-RISE projects. Their geographic signature bridges Europe and Southeast Asia.

What sets them apart

CMU offers European consortia a direct gateway to Southeast Asian academic networks and research infrastructure — a rare asset in H2020 where most third-country partners come from the Americas or East Asia. Their dual capability in biomedical materials and digital manufacturing gives them flexibility across different project themes. For consortium builders needing a credible Thai university partner with proven EU project experience, CMU is one of very few options with a track record.

Highlights from their portfolio

• MEDIPOL
  Their most recent and technically focused project, representing CMU's strategic pivot into biomedical polymer design for medical applications like wound dressings and ophthalmic drug delivery.
• SME 4.0
  A five-year MSCA-RISE project connecting CMU to the European smart manufacturing ecosystem, covering cyber-physical systems and mass customization for SMEs.
• CRISEA
  The only project where CMU received direct EC funding (EUR 100,000), focused on Southeast Asian regional integration — demonstrating their value as an area-studies knowledge provider.